ETC
IGMS

Exchange Traded Concepts’s IGM Biosciences IGMS Stock Holding History

Exchange Traded Concepts’s Portfolio IGMS Stock Details IGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10,572
Closed -$64.6K – 1348
2024
Q4 		$64.6K Hold
10,572
– – ﹤0.01% 1201
2024
Q3 		$175K Sell
10,572
-10,735
-50% -$118K ﹤0.01% 1004
2024
Q2 		$146K Sell
21,307
-6,628
-24% -$56.7K ﹤0.01% 908
2024
Q1 		$270K Buy
27,935
+8,887
+47% +$103K 0.01% 845
2023
Q4 		$158K Buy
19,048
+4,830
+34% +$28K ﹤0.01% 822
2023
Q3 		$119K Buy
14,218
+418
+3% +$3.55K ﹤0.01% 844
2023
Q2 		$127K Buy
+13,800
New +$155K ﹤0.01% 892

Other funds holding IGMS

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Exchange Traded Concepts's IGMS Position: Q1 2025 in Review

Exchange Traded Concepts sold out of IGM Biosciences (IGMS) in Q1 2025, closing a stake of 10,572 shares — an estimated $64.6K sold.

Exchange Traded Concepts first reported a position in IGMS in Q2 2023 and held it in 7 quarters. The position peaked at $270K in Q1 2024. 79 funds tracked by Wall St. Rank hold IGMS as of Q1 2025.

  • Exchange Traded Concepts reported no remaining IGM Biosciences position as of Q1 2025 after selling out during the quarter.
  • Exchange Traded Concepts sold 10,572 IGM Biosciences shares in Q1 2025, an estimated $64.6K.
  • Exchange Traded Concepts first reported a position in IGM Biosciences in Q2 2023 and held it in 7 quarters.
  • Exchange Traded Concepts's IGM Biosciences position peaked at $270K in Q1 2024.
  • 79 funds tracked by Wall St. Rank held IGM Biosciences as of Q1 2025.

Based on Exchange Traded Concepts's 13F filing for Q1 2025, filed 17 Apr 2025.